Innovative Biotherapies, Inc.
innbio
Ann Arbor, United States · Founded 2015 · $2.7M raised
- Headquarters
- Ann Arbor, Michigan
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Website
- innbio.com
- Total Funding
- $2.7M
- Last Round
- $2.7M GrantMay 2024
- Rounds
- 1
About
Innovative BioTherapies (IBT) develops bioartificial organ-based medical devices using adult progenitor cells, biomaterials, and MEMs technology. Its lead product, the Selective Cytopheretic Device (SCD), targets inflammatory conditions including Acute Kidney Injury, ARDS, and Multiple Organ Dysfunction. Founded in 2003 by Dr. H. David Humes, a University of Michigan professor of medicine.
Summary
Innovative Biotherapies, Inc. is a Biotech company based in Ann Arbor, United States, founded in 2015. It has raised $2.7M in total across 1 round, most recently a $2.7M Grant round in May 2024. Investors include National Institute of Health (NIH).
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...